VRTX NASDAQ
Vertex Pharmaceuticals Incorporated
1W: -3.8%
1M: -0.9%
3M: -9.1%
YTD: -4.1%
1Y: -3.0%
3Y: +25.6%
5Y: +99.7%
$434.52
+0.98 (+0.23%)
Weekly Expected Move ±3.1%
$410
$423
$437
$450
$463
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$12B
Revenue
+10.4% YoY
$4B
Net Income
+538.7% YoY
$4B
Free Cash Flow
+394.9% YoY
86.8%
Gross Margin
38.1%
Op. Margin
34.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE24.7%
ROA17.8%
ROIC25.2%
Valuation
P/E25.5
P/B5.7
EV/EBITDA21.5
Leverage
Debt/Equity0.21
Current Ratio2.90
Interest Cov.488.1x
Quality Scores
Piotroski F7/9
Altman Z11.35
Beneish M-2.21